These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34376950)

  • 1. Association of Acute Interstitial Nephritis with Nivolumab in Renal Cell Carcinoma: A Case Report.
    Noto-Kadou-Kaza B; Desbuissons G; Isnard CB
    Indian J Nephrol; 2021; 31(3):303-306. PubMed ID: 34376950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute interstitial nephritis after sequential ipilumumab - nivolumab therapy of metastatic melanoma.
    Bottlaender L; Breton AL; de Laforcade L; Dijoud F; Thomas L; Dalle S
    J Immunother Cancer; 2017 Jul; 5(1):57. PubMed ID: 28716106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute tubulointerstitial nephritis and IgM deposits on glomerular capillary walls after immunotherapy with nivolumab for metastatic renal cell carcinoma.
    Irifuku T; Satoh A; Tani H; Mandai K; Masaki T
    CEN Case Rep; 2020 Feb; 9(1):48-54. PubMed ID: 31605271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune checkpoint inhibitor (nivolumab)-associated kidney injury and the importance of recognizing concomitant medications known to cause acute tubulointerstitial nephritis: a case report.
    Koda R; Watanabe H; Tsuchida M; Iino N; Suzuki K; Hasegawa G; Imai N; Narita I
    BMC Nephrol; 2018 Feb; 19(1):48. PubMed ID: 29486725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [INTERSTITIAL NEPHRITIS CAUSED BY IPILIMUMAB AND NIVOLUMAB COMBINATION THERAPY FOR ADVANCED RENAL CELL CARCINOMA: A CASE REPORT].
    Ishii M; Takezawa K; Imamura R; Fukuhara S; Fujita K; Uemura M; Kiuchi H; Nonomura N
    Nihon Hinyokika Gakkai Zasshi; 2021; 112(2):109-112. PubMed ID: 35444079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A Case of Late Onset Nivolumab-Induced Interstitial Nephritis in a Patient with Metastatic Renal Cell Carcinoma].
    Hattahara K; Yamasaki T; Sawada A; Tanigaki K; Endo S; Teramoto Y; Banno H; Fuchigami Y; Suzuki R; Fujiwara M; Hida T; Yoshino T; Kita Y; Goto T; Akamatsu S; Saito R; Kobayashi T; Inoue T; Ogawa O
    Hinyokika Kiyo; 2019 May; 65(5):157-161. PubMed ID: 31247693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Nivolumab/Ipilimumab-Associated Autoimmune Nephritis during Steroid Therapy.
    Gebauer E; Bechtel-Walz W; Schell C; Erbel M; Walz G; Hermle T
    Case Rep Nephrol Dial; 2021; 11(3):270-274. PubMed ID: 34703826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-Challenging with Nivolumab in Metastatic Renal Cell Carcinoma After Immune-Related Interstitial Pneumonia: A Case Report.
    Shibata Y; Noguchi G; Suzuki T; Osaka K; Umemoto S; Kishida T
    Am J Case Rep; 2021 Aug; 22():e932924. PubMed ID: 34358221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute Interstitial Nephritis With Karyomegalic Epithelial Cells After Nivolumab Treatment-Two Case Reports.
    Ryuzaki M; Tokuyama H; Uchiyama K; Nakaya H; Hasegawa K; Miyashita K; Konishi K; Hashiguchi A; Wakino S; Itoh H
    Clin Med Insights Case Rep; 2019; 12():1179547619853647. PubMed ID: 31223235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azithromycin-Induced, Biopsy-Proven Acute Interstitial Nephritis in an Adult Successfully Treated with Low-Dose Corticosteroids.
    Woodruff AE; Meaney CJ; Hansen EA; Prescott GM
    Pharmacotherapy; 2015 Nov; 35(11):e169-74. PubMed ID: 26598102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reintroduction of nivolumab in a patient with gastric cancer after improvement of nivolumab-induced acute interstitial nephritis: a case report.
    Hu Q; Hasuda H; Ueki K; Tsuchimoto A; Zaitsu Y; Tsuda Y; Hisamatsu Y; Nakashima Y; Ando K; Kimura Y; Oki E; Mori M
    Int Cancer Conf J; 2020 Jul; 9(3):127-132. PubMed ID: 32582516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe acute interstitial nephritis after combination immune-checkpoint inhibitor therapy for metastatic melanoma.
    Murakami N; Borges TJ; Yamashita M; Riella LV
    Clin Kidney J; 2016 Jun; 9(3):411-7. PubMed ID: 27274826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute Interstitial Nephritis in a Patient with Non-Small Cell Lung Cancer under Immunotherapy with Nivolumab.
    Georgianos PI; Vaios V; Leontaridou E; Karayannopoulou G; Koletsa T; Sioulis A; Balaskas EV; Zebekakis PE
    Case Rep Nephrol; 2019; 2019():3614980. PubMed ID: 30775040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nivolumab-associated acute glomerulonephritis: a case report and literature review.
    Jung K; Zeng X; Bilusic M
    BMC Nephrol; 2016 Nov; 17(1):188. PubMed ID: 27876011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission tomography as an adjuvant diagnostic test in the evaluation of checkpoint inhibitor-associated acute interstitial nephritis.
    Qualls D; Seethapathy H; Bates H; Tajmir S; Heidari P; Endres P; Reynolds K; Lawrence D; Sise M
    J Immunother Cancer; 2019 Dec; 7(1):356. PubMed ID: 31864416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nivolumab-induced acute granulomatous tubulointerstitial nephritis in a patient with gastric cancer.
    Nakatani Y; Kawakami H; Ichikawa M; Yamamoto S; Otsuka Y; Mashiko A; Takashima Y; Ito A; Nakagawa K; Arima S
    Invest New Drugs; 2018 Aug; 36(4):726-731. PubMed ID: 29623482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute interstitial nephritis associated with immune checkpoint inhibitors: a single-centre experience.
    Oleas D; Bolufer M; Agraz I; Felip E; Muñoz E; Gabaldón A; Bury R; Espinel E; Serón D; García-Carro C; Soler MJ
    Clin Kidney J; 2021 May; 14(5):1364-1370. PubMed ID: 34221369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to combined ipilimumab and nivolumab after development of a nephrotic syndrome related to PD-1 monotherapy.
    Glutsch V; Grän F; Weber J; Gesierich A; Goebeler M; Schilling B
    J Immunother Cancer; 2019 Jul; 7(1):181. PubMed ID: 31300044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal change disease in a patient receiving checkpoint inhibition: Another possible manifestation of kidney autoimmunity?
    Vaughan E; Connolly E; Hui M; Chadban S
    Cancer Rep (Hoboken); 2020 Oct; 3(5):e1250. PubMed ID: 33085845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitiligo Adverse Event Observed in a Patient With Durable Complete Response After Nivolumab for Metastatic Renal Cell Carcinoma.
    Billon E; Walz J; Brunelle S; Thomassin J; Salem N; Guerin M; Vicier C; Dermeche S; Albiges L; Tantot F; Nenan S; Pignot G; Gravis G
    Front Oncol; 2019; 9():1033. PubMed ID: 31649889
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.